Pretherapy Imaging

Pretherapy Imaging is a diagnostic procedure category in nuclear medicine that specifically involves the administration of a radiolabeled ligand prior to therapeutic intervention to visualize, characterize, and quantify target expression in prostate cancer lesions for patient selection and dosimetry planning.

140

Publications

8.1K

Citations

1.1K

Authors

317

Institutions

Publications per year

2017–2026

48

Authors

1.1K

  1. ME
    Markus Essler

    University Hospital Bonn, Germany

    4 publications · 193 citations

    4

    h-index

  2. WJ
    Walter Jentzen

    University of Duisburg-Essen, Germany

    4 publications · 270 citations

    4

    h-index

  3. FG
    Florian Gaertner

    University Hospital Bonn, Germany

    4 publications · 193 citations

    4

    h-index

  4. MR
    Mack Roach

    University of California, San Francisco, United States

    3 publications · 187 citations

    3

    h-index

  5. YK
    Yuni K. Dewaraja

    University of Michigan, United States

    3 publications · 68 citations

    3

    h-index

1–5 of 1.1K

Venues

  1. 13

    h-index

  2. Radiology

    10 publications · 934 citations

    10

    h-index

  3. Clinical Nuclear Medicine

    CNM · 9 publications · 278 citations

    9

    h-index

  4. Journal of Nuclear Medicine

    8 publications · 936 citations

    8

    h-index

  5. 6

    h-index

1–5